Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation

PURPOSE: Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA for treatment of OAB refractory to initial SNM and identify patient characteristics associated with these outc...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int Neurourol J
Hlavní autoři: Trinh, Hamilton, Irish, Vicki, Diaz, Mireya, Atiemo, Humphrey
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Continence Society 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790822/
https://ncbi.nlm.nih.gov/pubmed/31607102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5213/inj.1938030.015
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky